Request for Administrative Supplements for Basic Research on Opioids to Existing Grant Awards

Notice Number: NOT-DA-18-014

Key Dates
Release Date:   June 25, 2018

Related Announcements
PA-18-591

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

In response to the opioid epidemic, the Division of Neuroscience and Behavior is requesting the submission of administrative supplements for basic research on opioids to existing grant applications.   Requests for administrative supplements should be within the scope of the existing parent grant.  Any cost increases need to result from making modifications to the project that would increase or preserve the overall impact of the project consistent with its originally approved objectives and purposes.  This notice is effective until August 2019.
  
Before submitting, grantees are encouraged to discuss a potential submission of an administrative supplement request with NIDA Program and Grants Management specialist. The telephone number and email address of your NIDA Program Officer and your NIDA Grants Specialist are available in the eRA Commons, on your Notice of Award, and are also available here, at NIH NED.
 
 NIDA staff will review the application and consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research. The parent grant must remain active for the entire period of the supplemental funding. Please note that a no-cost extension cannot be used to accommodate this requirement. All no-cost extensions must be in place prior to submitting a request for an administrative supplement. In some cases, additional expertise may be called upon to assist in the review.   Administrative supplement requests above $100,000 in direct costs will also be reviewed by the National Advisory Council on Drug Abuse.
 
Submitting your administrative supplement request:
 
Applicants should submit to PA-18-591 , Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)?, which details three ways to submit your request:

Inquiries

Please direct all inquiries to:

Roger Little, Ph.D.
National Institute on Drug Abuse
Telephone: 301-435-1316
Email: Roger.Little@nih.gov